Option chain shows key data for Galera Therapeutics's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Galera Therapeutics.

Galera Therapeutics (OTC:GRTX) Stock, Option Chain

Galera Therapeutics

Galera Therapeutics Inc is a biopharmaceutical company focused on developing and commercializing a pipeline of novel, proprietary therapeutics that have the potential to transform radiotherapy in cancer. The Firm's lead product candidate, avasopasem manganese, is a highly selective small molecule dismutase mimetic for severe oral mucositis (SOM) in patients with head and neck cancer (HNC), the reduction of esophagitis in patients with lung cancer, and the reduction of cisplatin-induced kidney damage in patients with cancer. The Firm's second product candidate, rucosopasem manganese, has been in development to augment the anti-cancer efficacy of stereotactic body radiation therapy (SBRT) in patients with non-small cell lung cancer (NSCLC) and locally advanced pancreatic cancer (LAPC).

Movers

News

Intraday Update

Markets

Trading Ideas

ADRT

ADSK

AFMD

BNAI

BPTH

CAMP

CGON

CNSP

COHR

CRKN

DELL

DHAC

DOGZ

DRCT

EFSH

FFIE

FOXO

GPCR

GRTX

IMCR

IPDN

ISPC

LQDA

LSCC

MBOT

MGNX

MOLN

NVAX

OLMA

Grupo Aeroportuario del Centro NorteB de CV

OMAB

PGEN

PRTG

PSNL

SAIC

SRCL

Vintage Wine Estates, Inc. - Common Stock

WBUY

YGMZ

Why Science Applications International Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Monday&#39;s Mid-Day Session

stock-market-6693060

Galera Therapeutics shares are trading lower by 34.8% during Monday&#39;s session. The company said its shares will be delisted due to non-compliance with Nasdaq&#39;s continued listing standards.

Why Galera Therapeutics (GRTX) Stock Is Nosediving

Penny Stocks

Small Cap

Pre-Market Outlook

APLT

AVTX

CLSK

CURV

DOMA

GUTS

MCAF

MDIA

NDRA

PAVM

SBFM

SINT

VSTE

VVOS

XTKG

ZPTA

Shares of  Doma Holdings Inc. (NYSE: DOMA) rose sharply in today’s pre-market trading after the company entered a merger transaction with TRG to go private at $6.29 per share in cash.

Doma Holdings shares jumped 34.1% to $6.09 in pre-market trading

Why Doma Holdings Shares Are Trading Higher By Around 34%; Here Are 20 Stocks Moving Premarket

GALERA THERAPEUTICS INC by Galera Therapeutics, Inc.

Galera Therapeutics Inc

Press Releases

Galera Adopts Limited Duration Stockholder Rights Agreement

Earnings

Galera Reports First Quarter 2024 Financial Results and Recent Corporate Updates

Comments

Galera Therapeutics

Galera Therapeutics (GRTX) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga